BEHRENS M KATHLEEN — SEC Form 4 filings
SEC reporting owner CIK 1211701. 16 Form 4 filings on record with FilingPulse; latest filed 2026-06-05.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-03-05 to 2026-06-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| IGM Biosciences, Inc. (IGMS) | Director | 8 | — | — | 11 |
| Sarepta Therapeutics, Inc. (SRPT) | Director | 6 | — | — | 11 |
| MIMEDX GROUP, INC. (MDXG) | Director | 2 | — | — | 2 |
Form 4 filings — BEHRENS M KATHLEEN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 16,875 | EDGAR |
| 2026-01-29 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 10,500 @ $13.71 · Tax withholding (F): 6,494 @ $22.17 · Option exercise (M): 10,500 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | IGM Biosciences, Inc. (IGMS) | Disposition to issuer (D): 22,222 · Disposition to issuer (D): 330,700 · Disposition to issuer (D): 29,807 · Disposition to issuer (D): 29,806 | EDGAR |
| 2025-07-02 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 1,471 @ $0 | EDGAR |
| 2025-06-23 | 4 | MIMEDX GROUP, INC. (MDXG) | Grant/award (A): 28,609 @ $6.47 | EDGAR |
| 2025-04-02 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 1,471 @ $0 | EDGAR |
| 2025-03-11 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 2,383 · Grant/award (A): 4,792 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 3,078 @ $0 | EDGAR |
| 2024-10-02 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 3,078 @ $0 | EDGAR |
| 2024-09-05 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Gift (G): 746 @ $0 | EDGAR |
| 2024-07-08 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 15,000 @ $13.90 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 3,078 @ $0 | EDGAR |
| 2024-06-06 | 4 | MIMEDX GROUP, INC. (MDXG) | Grant/award (A): 23,190 @ $7.26 | EDGAR |
| 2024-04-02 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 3,078 @ $0 | EDGAR |
| 2024-03-14 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 29,400 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 1,846 @ $0 · Grant/award (A): 3,679 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1211701 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →